The authors discuss androgen deprivation therapy (ADT) history, use of leuprolide, degarelix, and relugolix, with contextual use of ADT in combination with androgen-signaling inhibitors and potential mechanisms of resistance.
[Expert Opinion on Pharmacotherapy]
Sorry, but the selected Zotpress account can't be found.